Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany

Alitretinoin for Severe Chronic Hand Eczema

(2010) Mark Rodgers et al.   PHARMACOECONOMICS

The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases

(2009) Matthias Augustin et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool

(2009) C. Blome et al.   BRITISH JOURNAL OF DERMATOLOGY

Hand eczema and quality of life: a population-based study

(2009) C. Moberg et al.   BRITISH JOURNAL OF DERMATOLOGY

Measurement of patient-relevant benefits in the treatment of chronic hand eczema - a novel approach

(2009) Christine Blome et al.   CONTACT DERMATITIS

Guideline on the Management of Hand Eczema ICD-10 Code: L20. L23. L24. L25. L30

(2009) Thomas L. Diepgen et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial

(2008) T. Ruzicka et al.   BRITISH JOURNAL OF DERMATOLOGY

German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus

(2008) J.-Matthias Graf von der Schulenburg et al.   VALUE IN HEALTH